Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-13

Clinical Trial Update: Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of cyclosporine A with abacavir, lamivudine, zidovudine, and lopinavir/ritonavir in HIV infections has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine A (cyclosporine)
  • Lamivudine (lamivudine)
  • Lopinavir/ritonavir (lopinavir/ritonavir)
  • Zidovudine (Zidovudine)
  • abacavir sulfate (abacavir sulfate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-09-13